Clinical Trials
4
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Efficacy and Safety Study of GPX-150 to Treat Soft Tissue Sarcoma
- Conditions
- Soft Tissue Sarcoma
- Interventions
- Drug: GPX-150 for Injection
- First Posted Date
- 2014-10-17
- Last Posted Date
- 2018-01-10
- Lead Sponsor
- Gem Pharmaceuticals
- Target Recruit Count
- 22
- Registration Number
- NCT02267083
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸University of Iowa Holden Comprehensive Cancer Center, Iowa City, Iowa, United States
🇺🇸Washington University School of Medicine, Saint Louis, Missouri, United States
Safety Study of GPX-150 in Patients With Solid Tumors
- Conditions
- Advanced Solid Tumors - Phase 1 Population
- Interventions
- Drug: GPX-150 for Injection
- First Posted Date
- 2008-07-04
- Last Posted Date
- 2014-08-05
- Lead Sponsor
- Gem Pharmaceuticals
- Target Recruit Count
- 27
- Registration Number
- NCT00710125
- Locations
- 🇺🇸
University of Iowa Hospital and Clinics, Iowa City, Iowa, United States
Study of GPX-100 in the Treatment of Metastatic Breast Cancer
- Conditions
- Breast CancerMetastasis
- First Posted Date
- 2005-07-26
- Last Posted Date
- 2007-01-09
- Lead Sponsor
- Gem Pharmaceuticals
- Target Recruit Count
- 40
- Registration Number
- NCT00123877
- Locations
- 🇺🇸
Huntsman Cancer Center, University of Utah, Salt Lake City, Utah, United States
🇧🇬Sofia Cancer Center, Sofia, Bulgaria
🇧🇬University Hospital Queen Joanna, Sofia, Bulgaria
GPX-100 in Treating Patients With Solid Tumors
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2004-05-24
- Last Posted Date
- 2013-04-23
- Lead Sponsor
- Gem Pharmaceuticals
- Registration Number
- NCT00003403
- Locations
- 🇺🇸
Mayo Clinic Jacksonville, Jacksonville, Florida, United States
🇺🇸Huntsman Cancer Institute, Salt Lake City, Utah, United States